Am J Transl Res
January 2024
The present study aims to identify immune-related prognostic genes in colorectal cancer (CRC), and to explore potential mechanisms through which these genes regulate CRC progression. We first constructed a prognostic risk model based on seven gene signatures [cluster of differentiation-36 (), chemokine (C-X-C-motif) ligand 13 (), fibroblast growth factor receptor 4 (), gamma-amino-butyric acid type B receptor 1 (), lysosome-associated membrane glycoprotein 3 (), recombinant matrix metalloproteinase 12 (), and protein phosphatase 1H ()] using integrated bioinformatic analyses. , and were highly expressed in CRC cell lines (in comparison with a normal colonic epithelial cell line), while , and were weakly expressed.
View Article and Find Full Text PDFMedicine (Baltimore)
July 2021
Background: Ovarian cancer is one of the lethal gynecological diseases in women. However, using tumor microenvironment related genes to identify prognostic signature of ovarian cancer has not been discussed in detail.
Methods: The mRNA profiles of 386 ovarian cancer patients were retrieved from The Cancer Genome Atlas.